Idrebormilast
N/A
Report date: 2024/10/30 10:54:38
NME
Base Information
Drug NameIdrebormilast
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer IncUniversity Of Colorado Denver
Inactive CompaniesIcahn School Of Medicine At Mount Sinai
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A